LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Sorafenib	3.33	uM	LJP6	72	hr	1097	3110	3673	0.8471	0.8185
BT-20	AZD8055	3.33	uM	LJP6	72	hr	1097	906	3673	0.2468	-0.1038
BT-20	Sorafenib	1.11	uM	LJP6	72	hr	1097	3091	3673	0.8415	0.8115
BT-20	AZD7762	0.12	uM	LJP6	72	hr	1097	2846	3673	0.7742	0.7255
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1097	1423	3673	0.3873	0.1601
BT-20	AZD8055	1.11	uM	LJP6	72	hr	1097	1050	3673	0.2858	-0.0251
BT-20	AZD8055	10	uM	LJP6	72	hr	1097	119	3673	0.0326	-0.7198
BT-20	Sorafenib	0.37	uM	LJP6	72	hr	1097	3050	3673	0.8306	0.7963
BT-20	AT-7519	1.11	uM	LJP6	72	hr	1097	588	3673	0.1600	-0.3020
BT-20	AZD7762	0.04	uM	LJP6	72	hr	1097	3676	3673	1.0006	1.0000
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1097	750	3673	0.2042	-0.1962
BT-20	AZD7762	10	uM	LJP6	72	hr	1097	456	3673	0.1241	-0.3966
BT-20	AZD8055	0.12	uM	LJP6	72	hr	1097	1170	3673	0.3188	0.0367
BT-20	AZD8055	0.37	uM	LJP6	72	hr	1097	1116	3673	0.3039	0.0097
BT-20	AT-7519	0.04	uM	LJP6	72	hr	1097	3026	3673	0.8238	0.7896
BT-20	AZD7762	0.37	uM	LJP6	72	hr	1097	2115	3673	0.5756	0.4564
BT-20	Sorafenib	0.04	uM	LJP6	72	hr	1097	3411	3673	0.9288	0.9170
BT-20	Sorafenib	0.12	uM	LJP6	72	hr	1097	3487	3673	0.9497	0.9413
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1097	1875	3673	0.5105	0.3589
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1097	832	3673	0.2262	-0.1485
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1097	540	3673	0.1468	-0.3382
BT-20	AT-7519	10	uM	LJP6	72	hr	1097	529	3673	0.1442	-0.3420
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1097	1307	3673	0.3559	0.1055
BT-20	Alvocidib	0.04	uM	LJP6	72	hr	1097	1075	3673	0.2930	-0.0116
BT-20	Sorafenib	10	uM	LJP6	72	hr	1097	1328	3673	0.3613	0.1140

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)